:: SIHL ::

Company Profile

Smart Quotes

SANOFI INDIA LTD.

NSE : SANOFIBSE : 500674ISIN CODE : INE058A01010Industry : Pharmaceuticals & DrugsHouse : Sanofi India - MNC

BSE6176.403.6 (+0.06 %)

PREV CLOSE ( ) 6172.80

OPEN PRICE ( ) 6193.90

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 143

TODAY'S LOW / HIGH ( )6131.00 6216.80

52 WK LOW / HIGH ( )4145.9 10526.05

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 02-05 1956

Management Info

Aditya Narayan - Chairman - Managing Director

Registered Office

Address Sanofi House, C T S No. 117- B,L & T Business Park,Saki Vihar Road, Powai,
Mumbai,
Maharashtra-400072

Phone 022-2803 2000

Email igrc.sil@sanofi.com

Website www.sanofiindialtd.com

Registrar's Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

24May Sanofi India informs about change in m
Sanofi India has informed that upon the recommendation of the Nomination..

25Apr Sanofi India informs about disclosure
In compliance with Regulation 30 of the SEBI (LODR) Regulations, Sanofi..

24Apr Sanofi India informs about disclosure
In compliance with Regulation 30 of the SEBI (LODR) Regulations, Sanofi..

16Apr Sanofi India informs about press release
Sanofi India has informed that it enclosed copies of the newspaper adver..

09Apr Sanofi India informs about compliance
Sanofi India has informed that it enclosed Certificate under Regulation..

Financials

in Crores

	QTR Mar 25	ANNUAL 24
Net Profit	119.5	413.5
Gross Profit	165.3	431.4
Operating Profit	175.2	507.3
Net Sales	535.9	2013.2

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE) 31699.95 (1.33%)	M.Cap ( in Cr)67360.18
Astrazeneca Pharma I (BSE) 9891.10 (4.25%)	M.Cap ( in Cr)24727.75
Glenmark Pharma (BSE) 1585.10 (4.62%)	M.Cap ( in Cr)44731.65
Hester Biosciences (BSE) 1871.10 (3.73%)	M.Cap ( in Cr)1591.72
Lupin (BSE) 1995.30 (2.69%)	M.Cap ( in Cr)91124.45

Shareholding Pattern

	PROMOTERS	60.4%
	FI/BANKS/INSURANCE	11.75%
	MUTUAL FUNDS/UTI	11.26%
	NON-INSTITUTION	11.01%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Baroda BNP Paribas Small Cap Fund-Reg(G)	1.68
Nippon India Pharma Fund(G)	1.63
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)	1.62
PGIM India Healthcare Fund-Reg(G)	1.59
SBI Magnum Midcap Fund-Reg(G)	1.16
Baroda BNP Paribas Mid Cap Fund-Reg(G)	1.01
Baroda BNP Paribas Value Fund-Reg(G)	0.96

SIHL House, Opp.Ambawadi Jain Temple, Nehrunagar Cross Roads, Ahmedabad-380015

Prevent Unauthorised transactions in your account. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020. Update your email id and mobile number with your stock broker / depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge as well as for mobile no and for email id updation.Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month........... Issued in the interest of Investors".

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account

REGISTRATION NO

SEBI Regn.no. INZ000167335 Member Code: NSE-07590 BSE Sebi Regn. 943 AMFI ARN- 39843 SEBI Registration No. (DP)- IN-DP-465-2020 NSDL:IN-DP-NSDL-34-97,DP ID:IN300343 CDSL:IN-DP-CSDL-199-2003,DP ID:12029300 Approved person Registration no. with NSDL Database Management Limited(NDML) :IRDA/IR1/2013/004Approved person Registration no. with Center Insurance Repository Limited (CIR): IRDA/IR2/2013/123

REGISTERED ADDRESS:

810, X-Change Plaza, DSCCSL (53E), Road 5E, Block 53, Zone 5, Gift City, Gandhinagar 382050

SHAH INVESTOR'S HOME LTD. CIN NO:-U67120GJ1994PLC023257 SIHL COMMODITIES LTD. CIN NO:-U45201GJ1995PLC025825SIHL CONSULTANCY LTD. CIN NO:-U74140GJ2006PLC049662 SIHL FINCAP LTD.CIN NO:-U65923GJ2006PLC049661 SIHL GLOBAL INVESTMENTS (IFSC) PVT. LTD. CIN NO:-U67190GJ2016PTC094444NSEL MemberCode :10560

CORRESPONDENCE ADDRESS:

SIHL House, Opp. Ambawadi Jain Temple, Nehrunagar Cross Road, Ahmedabad-380015.

For any complains email us at investors@sihl.in Shah Investor's Home Ltd. Member: